The Clinical Utility of DNA Methylation Testing in Patient-collected Urine and Vaginal Samples to Detect Endometrial Cancer: a Case-control Study
Recruiting
Observational Study
Endometrial Cancer
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
Healthy Volunteers Welcome
You do not need to have the condition being studied to take part.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 60 and older
- Sex
- Female
- Study type
- Observational
- Participants needed
- 120 (estimated)
- Sponsor
- University of Aarhus · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
The goal of this observational case-control study is to investigate the use of DNA-methylation testing in patient-collected urine and vaginal samples to detect endometrial cancer. The study aims to answer the following questions:
* Can DNA methylation testing in vaginal and full-void urine samples distinguish endometrial cancer cases from healthy controls?
Researchers will compare patient-collec…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Patients with endometrial cancer (cases): Inclusion Criteria:
* Women ≥ 60 years
* Diagnosed with cancer corpus uteri
* Living in Central Denmark Region or Southern Denmark Region, Denmark
* Able to provide written consent for participation
* Able to read and understand Danish
Patients with endome…
Contacts